Effects of a new 12-lipoxygenase inhibitor, daphnodorin A, on angiotensin II-induced vascular contraction in hamster

被引:4
作者
Takai, S [1 ]
Jin, D
Sakaguchi, M
Kirimura, K
Ikeda, J
Baba, K
Fujita, T
Miyazaki, M
机构
[1] Osaka Med Coll, Dept Pharmacol, Takatsuki, Osaka 5698686, Japan
[2] Osaka Univ Pharmaceut Sci, Dept Pharmacognosy, Takatsuki, Osaka 5691041, Japan
[3] Osaka Univ Pharmaceut Sci, Dept Hyg Chem, Takatsuki, Osaka 5691041, Japan
来源
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 1999年 / 60卷 / 02期
关键词
D O I
10.1054/plef.1998.0020
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We studied whether lipoxygenase inhibition suppressed angiotensin Ii-induced vascular contraction. In the present study, we used a new 12-lipoxygenase inhibitor, daphnodorin A, and an analogue of daphnodorin A, daphnodorin B, which has no inhibitory effects on 12-lipoxygenase. Daphnodorin A at 30 mu M and 100 mu M significantly suppressed the contractile responses induced by angiotensin II (3 x 10(-8) M) in isolated hamster aorta, while daphnodorin B up to 100 mu M did not affect the responses. These results suggest that daphnodorin A, but not daphnodorin B, may suppress angiotensin II-induced vascular contractile responses through the inhibition of 12-lipoxygenase.
引用
收藏
页码:135 / 138
页数:4
相关论文
共 19 条
[1]  
BABA K, 1986, CHEM PHARM BULL, V34, P595
[2]  
BABA K, 1986, CHEM PHARM BULL, V34, P1540
[3]   MYOPLASMIC CA-2+-FORCE RELATIONSHIP STUDIED WITH FURA-2 DURING STIMULATION OF RAT AORTIC SMOOTH-MUSCLE [J].
BRUSCHI, G ;
BRUSCHI, ME ;
REGOLISTI, G ;
BORGHETTI, A .
AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 254 (05) :H840-H854
[4]   VASCULAR ANGIOTENSIN CONVERTING ENZYME IN THE DEVELOPMENT OF RENAL-HYPERTENSION [J].
MIYAZAKI, M ;
OKAMURA, T ;
OKUNISHI, H ;
TODA, N .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1986, 8 :S58-S61
[5]  
MIYAZAKI M, 1996, J HYPERTENS S1, V14, pS138
[6]   INDUCTION OF THE PROTOONCOGENE C-JUN BY ANGIOTENSIN-II [J].
NAFTILAN, AJ ;
GILLILAND, GK ;
ELDRIDGE, CS ;
KRAFT, AS .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (10) :5536-5540
[7]   ROLE OF THE LIPOXYGENASE PATHWAY IN ANGIOTENSIN-II-INDUCED VASCULAR SMOOTH-MUSCLE CELL HYPERTROPHY [J].
NATARAJAN, R ;
GONZALES, N ;
LANTING, L ;
NADLER, J .
HYPERTENSION, 1994, 23 (01) :I142-I147
[8]   INHIBITION OF LIPOXYGENASE PATHWAY REDUCES BLOOD-PRESSURE IN RENOVASCULAR HYPERTENSIVE RATS [J].
NOZAWA, K ;
TUCK, ML ;
GOLUB, M ;
EGGENA, P ;
NADLER, JL ;
STERN, N .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (06) :H1774-H1780
[9]   VASCULAR RENIN-ANGIOTENSIN SYSTEM IN 2-KIDNEY, ONE CLIP HYPERTENSIVE RATS [J].
OKAMURA, T ;
MIYAZAKI, M ;
INAGAMI, T ;
TODA, N .
HYPERTENSION, 1986, 8 (07) :560-565
[10]  
RYAN MJ, 1984, J PHARMACOL EXP THER, V228, P312